Abstract |
|
Authors | Anton Buchner, Reiner Elsässer, Peter Bias |
Journal | Breast cancer research and treatment
(Breast Cancer Res Treat)
Vol. 148
Issue 1
Pg. 107-16
(Nov 2014)
ISSN: 1573-7217 [Electronic] Netherlands |
PMID | 25261291
(Publication Type: Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Recombinant Proteins
- Taxoids
- Granulocyte Colony-Stimulating Factor
- Docetaxel
- pegfilgrastim
- Polyethylene Glycols
- Doxorubicin
- Filgrastim
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects)
- Breast Neoplasms
(drug therapy)
- Docetaxel
- Dose-Response Relationship, Drug
- Double-Blind Method
- Doxorubicin
(administration & dosage)
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor
(administration & dosage, therapeutic use)
- Humans
- Male
- Middle Aged
- Neutropenia
(chemically induced, prevention & control)
- Polyethylene Glycols
- Recombinant Proteins
(administration & dosage, therapeutic use)
- Taxoids
(administration & dosage)
|